Dianthus Therapeutics, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal antibody engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein; and DNTH212, a bifunctional fusion protein that targets plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell function. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| FidelityFMR | fundamental | 7.77M | $651.86M | 0.03% | Added+20.8% | 2026-03-31 |
| Wellington | fundamental | 2.60M | $217.84M | 0.04% | Added+3.7% | 2026-03-31 |
| StateStreet | passive | 1.40M | $117.40M | 0.00% | Trimmed-7.2% | 2026-03-31 |
| Citadel | multi-strat | 643.6K | $54.01M | 0.07% | Trimmed-44.8% | 2026-03-31 |
| DEShaw | quant | 149.6K | $12.56M | 0.01% | Trimmed-3.3% | 2026-03-31 |
| TRowePrice | fundamental | 1.15M | $96.25K | 0.01% | Added+86.2% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-06upcoming | -0.91 | — | — |
| 2026-05-05 | -1.10 | -0.85 | +22.93% |
| 2026-03-09 | -1.03 | -1.43 | -38.64% |
| 2025-11-05 | -0.90 | -0.97 | -7.95% |
| 2025-08-07 | -0.87 | -0.88 | -1.54% |
| 2025-05-12 | -0.71 | -0.82 | -15.49% |
| 2025-03-11 | -0.76 | -0.70 | +7.91% |
| 2024-11-07 | -0.60 | -0.74 | -23.13% |
| 2024-08-08 | -0.55 | -0.51 | +6.52% |
| 2024-05-09 | -0.44 | -0.54 | -23.29% |
| 2024-03-21 | -1.02 | -0.71 | +30.12% |
| 2023-11-09 | -0.56 | -3.78 | -575.00% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| DNTH | +6.39% | +67.92% | +125.70% | +434.85% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | +3.43% | +72.56% | +129.14% | +422.16% |